The global pet cancer therapeutics market size is set to reach US$ 405.90 billion in 2023. Overall sales of cancer therapeutics are likely to surge at 10% CAGR, taking the forecasted market valuation to US$ 1052.80 billion by the end of 2033. The rising incidence of cancer in cats and dogs, as well as the substantial investments in R&D activities related to oncology treatment and …
Category Archives: Healthcare Trends
Durable Medical Equipment Rental Market in Japan is projected to register a CAGR of nearly 7.4% during 2023 to 2033 | FMI Analyst
According to a newly released Durable Medical Equipment Rental Market analysis report by Future Market Insights, revenue from the Durable Medical Equipment Rental Market in 2022 was valued at US$ 25.7 billion. The market is expected to reach US$ 47 billion by 2033, with a CAGR of 5.7% from 2023 to 2033. Hospitals are expected …
Disposable EEG Electrode Market in Japan is projected to register a CAGR of nearly 4.8% from 2023 to 2033 | FMI
According to the recently released Disposable EEG Electrode Market analysis report from Future Market Insights, global sales of the Disposable EEG Electrode Market in 2022 will be US$ 782 Million. The market is expected to be worth US$ 1.2 Billion by 2033, with a 4.3% CAGR between 2023 and 2033. Needle Electrodes are expected to be the most profitable segment between 2023 and …
Cytokine Release Syndrome Management Market to expand at a CAGR of 6.7% by 2033 | FMI Project
The global Cytokine Release Syndrome Management Market is expected to reach US$ 23.32 billion in 2023, with a 6.7% CAGR from 2023 to 2033. In the coming years, the market for CRS management is expected to grow due to an increase in the number of autoimmune diseases and cancers. The development of novel therapies for …
Chronic Granulomatous Disease (CGD) Management Market is expected to reach US$ 2.11 Billion by 2033, at a CAGR of 4.9%
During the forecast period 2023-2033, the Chronic Granulomatous Disease (CGD) Management Market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Granulomatous disease (CGD) management is expected to rise up to a market valuation of US$ 2.11 Billion. It is …
Prosthetics and Orthotics Market is expected to reach a valuation of US$ 12.2 Billion by 2033, at a CAGR of 6% | FMI Study
According to Future Market Insights’ newly released Prosthetics and Orthotics Market study report, worldwide Prosthetics & Orthotics Market sales in 2022 are expected to be US$ 6.5 billion. The market is expected to exceed US$ 12 billion by 2033, with a CAGR of 6% from 2023 to 2033. The Orthotics market is estimated to create …
Triple X Syndrome Management Market to expand at a 6% value CAGR by 2033 | FMI Project
The global Triple X Syndrome Management Market is projected to grow at a healthy CAGR of 6% from 2023 to 2033. The market is slated to amass a revenue of US$ 268.63 million by 2033 as opposed to US$ 150 million in 2023. Research initiatives and other projects from several organizations have significantly benefitted the triple …
Anti-Ageing Products, Services and Devices Market is anticipated to reach US$ 109.8 billion by 2033
The Anti-Ageing Products, Services, and Devices market demand is expected to grow at a compound annual growth rate (CAGR) of 5.5% between 2023 and 2033, according to industry projections. By 2022, the market for anti-aging products was anticipated to be worth US$ 59 billion, and Future Market Insights (FMI) predicts that revenue from the market …
Drug Formulation Market is expected to reach US$ 2.87 Triillion by 2032, exhibiting growth at a CAGR of 5.6%
The global drug formulation market demand is projected to grow at a CAGR of 5.6% between 2022 and 2032. Pharmaceutical Formulations market was held at around US$ 1.58 trillion by 2022 and is expected to reach US$ 2.87 Trillion by 2032. According to the study, oral formulations are anticipated to experience exponential growth, with a …
Inhalation and Nasal Spray Generic Drugs Market is likely to register CAGR of 8.96% through 2033
The global Inhalation and Nasal Spray Generic Drugs market demand is predicted to experience a moderate growth rate of 8.96% during the forecast period. As of 2023, the market is valued at US$ 20.78 billion, and it is projected to reach US$ 49.01 billion by 2033. The sales of inhalation and nasal spray generic drugs …